A primer for achieving glycemic control in the cardiac surgical patient.
Maintaining glycemic control (blood glucose <180 mg/dL) has been shown to reduce morbidity and enhance long-term survival in patients with diabetes mellitus following coronary artery bypass graft (CABG) surgery. In this review we present a management strategy to achieve perioperative glycemic control in all patients undergoing CABG surgery, with and without diabetes mellitus, designed to achieve compliance with current Surgical Care Improvement Project (SCIP) and Society of Thoracic Surgeons (STS) guidelines.
Section of Endocrinology, Diabetes, Nutrition and Weight Management, the Boston University, School of Medicine, Boston, Massachusetts, USA. marie.mcdonnell@bmc.org
Marie E
ME
McDonnell
Sara M
SM
Alexanian
Lynn
L
White
Harold L
HL
Lazar
D001026:Coronary Artery Bypass; D003422:Critical Care / Q000379:methods / Q000592:standards; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D006801:Humans; D006943:Hyperglycemia / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007431:Intraoperative Complications / Q000175:diagnosis / Q000517:prevention & control*; D010351:Patient Discharge; D019990:Perioperative Care / Q000379:methods* / Q000592:standards; D011183:Postoperative Complications / Q000175:diagnosis / Q000517:prevention & control*; D017410:Practice Guidelines as Topic
D007004:Hypoglycemic Agents; D007328:Insulin